drugset / Trial / NCT02451488
Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma
RandomizedParallel-groupOpen-labelTreatment
Summary
Randomized trial to determine if neo-adjuvant subcutaneous GM-CSF restores the host regional lymph node immunity
Timeline
- Start
- 2015-05
- Primary completion
- 2016-11-04
- Completion
- 2016-11-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sargramostim | Protein / enzyme biologic | 125 ug/m2 | Subcutaneous |